Different collagen types define two types of idiopathic epiretinal membranes

Histopathology

Volumn 58, Issue 6, 2011, Pages 953-965

  Kritzenberger, Michaela ^a   Junglas, Benjamin ^a   Framme, Carsten ^b,d   Helbig, Horst ^b   Gabel, Veit Peter ^b   Fuchshofer, Rudolf ^a   Tamm, Ernst R ^a   Hillenkamp, Jost ^c  

^a Institute of Human Anatomy and Embryology   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d University Eye Clinic Bern   (Switzerland)

Author keywords

Collagen type III; Collagen type VI; Epiretinal membrane; Immunogold techniques; Immunohistochemistry; Transmission electron microscopy; Western blotting

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 6;

ARTICLE; CELLOPHANE MACULAR REFLEX; CLINICAL ARTICLE; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; EPIRETINAL MEMBRANE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOGOLD STAINING; IMMUNOHISTOCHEMISTRY; PRERETINAL MACULAR FIBROSIS; PRIORITY JOURNAL; RETINA DISEASE; RETINA MACULA LUTEA; RETINA MACULOPATHY; WESTERN BLOTTING;

COLLAGEN TYPE I; COLLAGEN TYPE II; COLLAGEN TYPE VI; EPIRETINAL MEMBRANE; EXTRACELLULAR MATRIX; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MICROSCOPY, ELECTRON;

EID: 79956069885     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03820.x     Document Type: Article

References (75)

1. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int. J. Biochem. Cell Biol. 2004; 36; 1031-1037.
2. Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology 1997; 104; 1033-1040.
3. Klein R, Klein BE, Wang Q, Moss SE. The epidemiology of epiretinal membranes. Trans. Am. Ophthalmol. Soc. 1994; 92; 403-425; discussion 425-430.
4. Fraser-Bell S, Ying-Lai M, Klein R, Varma R. Prevalence and associations of epiretinal membranes in Latinos: the Los Angeles Latino Eye Study. Invest. Ophthalmol. Vis. Sci. 2004; 45; 1732-1736.
5. Tanikawa A, Horiguchi M, Kondo M, Suzuki S, Terasaki H, Miyake Y. Abnormal focal macular electroretinograms in eyes with idiopathic epimacular membrane. Am. J. Ophthalmol. 1999; 127; 559-564.
6. Tanenbaum HL, Schepens CL, Elzeneiny I, Freeman HM. Macular pucker following retinal detachment surgery. Arch. Ophthalmol. 1970; 83; 286-293.
7. Trese M, Chandler DB, Machemer R. Macular pucker. II. Ultrastructure. Graefes Arch. Clin. Exp. Ophthalmol. 1983; 221; 16-26.
8. Wise GN. Relationship of idiopathic preretinal macular fibrosis to posterior vitreous detachment. Am. J. Ophthalmol. 1975; 79; 358-362.
9. Ciulla TA, Pesavento RD. Epiretinal fibrosis. Ophthalmic Surg. Lasers 1997; 28; 670-679.
10. Appiah AP, Hirose T, Kado M. A review of 324 cases of idiopathic premacular gliosis. Am. J. Ophthalmol. 1988; 106; 533-535.
11. Roth AM, Foos RY. Surface wrinkling retinopathy in eyes enucleated at autopsy. Trans. Am. Acad. Ophthalmol. Otolaryngol. 1971; 75; 1047-1058.
12. Pournaras CJ, Donati G, Brazitikos PD, Kapetanios AD, Dereklis DL, Stangos NT. Macular epiretinal membranes. Semin. Ophthalmol. 2000; 15; 100-107.
13. Hiscott PS, Grierson I, McLeod D. Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br. J. Ophthalmol. 1985; 69; 810-823.
14. Fraser-Bell S, Guzowski M, Rochtchina E, Wang JJ, Mitchell P. Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology 2003; 110; 34-40.
15. Wise GN. Clinical features of idiopathic preretinal macular fibrosis. Schoenberg Lecture. Am. J. Ophthalmol. 1975; 79; 349-357.
16. Jacobsen CH. Epiretinal membranes. Optom. Clin. 1996; 5; 77-94.
17. Hillenkamp J, Saikia P, Herrmann WA, Framme C, Gabel VP, Sachs HG. Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial. Graefes Arch. Clin. Exp. Ophthalmol. 2007; 245; 973-979.
18. Karnovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron-microscopy. J. Cell Biol. 1965; 27; 137-138.
19. Richardson KC, Jarret L, Finke H. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol. 1960; 35; 313-323.
20. Reynolds ES. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol. 1963; 17; 208-212.
21. Fuchshofer R, Yu AH, Welge-Lüssen U, Tamm ER. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 2007; 48; 715-726.
22. Bruns R. Beaded filaments and long spacing fibrils: relation to type VI collagen. J. Ultrastruct. Res. 1984; 89; 136-145.
23. Tamm E, Jungkunz W, Marsch WC, Lütjen-Drecoll E. Increase in types IV and VI collagen in cherry haemangiomas. Arch. Dermatol. Res. 1992; 284; 275-282.
24. Bruns RR, Press W, Engvall E, Timpl R, Gross J. Type VI collagen in extracellular, 100-nm periodic filaments and fibrils: identification by immunoelectron microscopy. J. Cell Biol. 1986; 103; 393-404.
25. Knupp C, Pinali C, Munro PM et al. Structural correlation between collagen VI microfibrils and collagen VI banded aggregates. J. Struct. Biol. 2006; 154; 312-326.
26. Knupp C, Amin SZ, Munro PM, Luthert PJ, Squire JM. Collagen VI assemblies in age-related macular degeneration. J. Struct. Biol. 2002; 139; 181-189.
27. Knupp C, Chong NH, Munro PM, Luthert PJ, Squire JM. Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy. J. Struct. Biol. 2002; 137; 31-40.
28. Oda Y, Kawahara E, Minamoto T et al. Immunohistochemical studies on the tissue localization of collagen types I, III, IV, V and VI in schwannomas. Correlation with ultrastructural features of the extracellular matrix. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1988; 56; 153-163.
29. Rittig M, Tittor F, Lütjen-Drecoll E, Mollenhauer J, Rauterberg J. Immunohistochemical study of extracellular material in the aged human synovial membrane. Mech. Ageing Dev. 1992; 64; 219-234.
30. Schlumberger W, Thie M, Rauterberg J, Kresse H, Robenek H. Deposition and ultrastructural organization of collagen and proteoglycans in the extracellular matrix of gel-cultured fibroblasts. Eur. J. Cell Biol. 1989; 50; 100-110.
31. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest. Ophthalmol. Vis. Sci. 1987; 28; 506-514.
32. Von der Mark H, Aumailley M, Wick G, Fleischmajer R, Timpl R. Immunochemistry, genuine size and tissue localization of collagen VI. Eur. J. Biochem. 1984; 142; 493-502.
33. Tamm E, Baur A, Lütjen-Drecoll E. Synthesis of extracellular matrix components by human ciliary muscle cells in culture. Curr. Eye Res. 1992; 11; 333-341.
34. Reale E, Groos S, Luciano L, Eckardt C, Eckardt U. In the mammalian eye type VI collagen tetramers form three morphologically different aggregates. Matrix Biol. 2001; 20; 37-51.
35. Kuo H-J, Keene DR, Glanville RW. Orientation of type VI collagen monomeres in molecular aggregates. Biochemistry 1989; 28; 3757-3762.
36. Foos RY. Vitreoretinal juncture; epiretinal membranes and vitreous. Invest. Ophthalmol. Vis. Sci. 1977; 16; 416-422.
37. Ponsioen TL, van Luyn MJ, van der Worp RJ, van Meurs JC, Hooymans JM, Los LI. Collagen distribution in the human vitreoretinal interface. Invest. Ophthalmol. Vis. Sci. 2008; 49; 4089-4095.
38. Scheiffarth OF, Kampik A, Gunther H, von der Mark K. Proteins of the extracellular matrix in vitreoretinal membranes. Graefes Arch. Clin. Exp. Ophthalmol. 1988; 226; 357-361.
39. Okada M, Ogino N, Matsumura M, Honda Y, Nagai Y. Histological and immunohistochemical study of idiopathic epiretinal membrane. Ophthalmic Res. 1995; 27; 118-128.
40. Ioachim E, Stefaniotou M, Gorezis S, Tsanou E, Psilas K, Agnantis NJ. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy. Eur. J. Ophthalmol. 2005; 15; 384-391.
41. Immonen I, Tervo K, Virtanen I, Laatikainen L, Tervo T. Immunohistochemical demonstration of cellular fibronectin and tenascin in human epiretinal membranes. Acta Ophthalmol. (Copenh.) 1991; 69; 466-471.
42. Jerdan JA, Pepose JS, Michels RG et al. Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology 1989; 96; 801-810.
43. Morino I, Hiscott P, McKechnie N, Grierson I. Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Br. J. Ophthalmol. 1990; 74; 393-399.
44. Grisanti S, Heimann K, Wiedemann P. Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy. Br. J. Ophthalmol. 1993; 77; 238-242.
45. Casaroli Marano RP, Vilaro S. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 1994; 35; 2791-2803.
46. Kuo HJ, Maslen CL, Keene DR, Glanville RW. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J. Biol. Chem. 1997; 272; 26522-26529.
47. Keene DR, Engvall E, Glanville RW. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. J. Cell Biol. 1988; 107; 1995-2006.
48. Senga K, Kobayashi M, Hattori H et al. Type VI collagen in mouse masseter tendon, from osseous attachment to myotendinous junction. Anat. Rec. 1995; 243; 294-302.
49. Bonaldo P, Russo V, Bucciotti F, Doliana R, Colombatti A. Structural and functional features of the alpha 3 chain indicate a bridging role for chicken collagen VI in connective tissues. Biochemistry 1990; 29; 1245-1254.
50. Bidanset DJ, Guidry C, Rosenberg LC, Choi HU, Timpl R, Hook M. Binding of the proteoglycan decorin to collagen type VI. J. Biol. Chem. 1992; 267; 5250-5256.
51. Kampik A, Green WR, Michels RG, Nase PK. Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am. J. Ophthalmol. 1980; 90; 797-809.
52. Kampik A, Kenyon KR, Michels RG, Green WR, de la Cruz ZC. Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch. Ophthalmol. 1981; 99; 1445-1454.
53. Messmer EM, Heidenkummer HP, Kampik A. Ultrastructure of epiretinal membranes associated with macular holes. Graefes Arch. Clin. Exp. Ophthalmol. 1998; 236; 248-254.
54. Rodrigues MM, Newsome DA, Machemer R. Further characterization of epiretinal membranes in human massive periretinal proliferation. Curr. Eye Res. 1981; 1; 311-315.
55. Hiscott PS, Grierson I, Trombetta CJ, Rahi AH, Marshall J, McLeod D. Retinal and epiretinal glia-an immunohistochemical study. Br. J. Ophthalmol. 1984; 68; 698-707.
56. Vinores SA, Campochiaro PA, Conway BP. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest. Ophthalmol. Vis. Sci. 1990; 31; 14-28.
57. Bochaton-Piallat ML, Kapetanios AD, Donati G, Redard M, Gabbiani G, Pournaras CJ. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 2000; 41; 2336-2342.
58. Guidry C, Bradley KM, King JL. Tractional force generation by human muller cells: growth factor responsiveness and integrin receptor involvement. Invest. Ophthalmol. Vis. Sci. 2003; 44; 1355-1363.
59. Guidry C. The role of Müller cells in fibrocontractive retinal disorders. Prog. Retin. Eye Res. 2005; 24; 75-86.
60. Guidry C, King JL, Mason JO. Fibrocontractive Müller cell phenotypes in proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2009; 50; 1929-1939.
61. Moreels M, Vandenabeele F, Dumont D, Robben J, Lambrichts I. Alpha-smooth muscle actin (alpha-SMA) and nestin expression in reactive astrocytes in multiple sclerosis lesions: potential regulatory role of transforming growth factor-beta 1 (TGF-beta1). Neuropathol. Appl. Neurobiol. 2008; 34; 532-546.
62. Abd-el-Basset EM, Fedoroff S. Immunolocalization of the alpha isoform of smooth muscle actin in mouse astroglia in cultures. Neurosci. Lett. 1991; 125; 117-120.
63. Lecain E, Alliot F, Laine MC, Calas B, Pessac B. Alpha isoform of smooth muscle actin is expressed in astrocytes in vitro and in vivo. J. Neurosci. Res. 1991; 28; 601-606.
64. Buniatian GH, Gebhardt R, Mecke D, Traub P, Wiesinger H. Common myofibroblastic features of newborn rat astrocytes and cirrhotic rat liver stellate cells in early cultures and in vivo. Neurochem. Int. 1999; 35; 317-327.
65. Hara A. Myoastrocytes in vitreous membrane in nontraumatic giant retinal tear. Jpn. J. Ophthalmol. 1985; 29; 177-186.
66. Smiddy WE, Green WR, Michels RG, de la Cruz Z. Ultrastructural studies of vitreomacular traction syndrome. Am. J. Ophthalmol. 1989; 107; 177-185.
67. Ponsioen TL, van Luyn MJ, van der Worp RJ, Pas HH, Hooymans JM, Los LI. Human retinal Muller cells synthesize collagens of the vitreous and vitreoretinal interface in vitro. Mol. Vis. 2008; 14; 652-660.
68. Fuchshofer R, Birke M, Welge-Lüssen U, Kook D, Lütjen-Drecoll E. Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest. Ophthalmol. Vis. Sci. 2005; 46; 568-578.
69. Neumann C, Yu A, Welge-Lussen U, Lutjen-Drecoll E, Birke M. The effect of TGF-beta2 on elastin, type VI collagen, and components of the proteolytic degradation system in human optic nerve astrocytes. Invest. Ophthalmol. Vis. Sci. 2008; 49; 1464-1472.
70. Tamm ER, Siegner A, Baur A, Lütjen-Drecoll E. Transforming growth factor-b1 induces a-smooth muscle-actin expression in cultured human and monkey trabecular meshwork. Exp. Eye Res. 1996; 62; 389-397.
71. Flügel-Koch C, Ohlmann A, Piatigorsky J, Tamm ER. Disruption of anterior segment development by TGF-beta1 overexpression in the eyes of transgenic mice. Dev. Dyn. 2002; 225; 111-125.
72. Hales AM, Schulz MW, Chamberlain CG, McAvoy JW. TGF-b1 induces lens cells to accumulate α-smooth muscle actin, a marker for subcapsular cataracts. Curr. Eye Res. 1994; 13; 885-890.
73. Gamulescu MA, Chen Y, He S et al. Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp. Eye Res. 2006; 83; 212-222.
74. Kurosaka H, Kurosaka D, Kato K, Mashima Y, Tanaka Y. Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts. Invest. Ophthalmol. Vis. Sci. 1998; 39; 699-704.
75. Kurosaka D, Muraki Y, Inoue M, Katsura H. TGF-beta 2 increases alpha-smooth muscle actin expression in bovine retinal pigment epithelial cells. Curr. Eye Res. 1996; 15; 1144-1147.